Registered Nurse in Nampa, ID Accepting Medicare
29 Registered Nurse nurses found. Showing 21 - 29
 Heather Collins, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1127 Caldwell Blvd, Nampa, ID 83651 Phone: 208-465-4935 |
Heidi Harrison, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 704 Alturas St, Nampa, ID 83686 Phone: 510-862-2338 |
Deo M Peppersack, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 217 W Georgia Ave Ste 120, Nampa, ID 83686 Phone: 208-498-1760 Fax: 208-498-1761 |
Kate Clark, FNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 207 1st St S, Nampa, ID 83651 Phone: 208-466-7869 Fax: 208-466-5359 |
Teresa Ann Dixon, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 120 9th Ave S Ste 110, Nampa, ID 83651 Phone: 208-369-6467 Fax: 208-463-4516 |
Ms. Sharon M Baldwin, CNS Registered Nurse - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 207 16th Ave N, Nampa, ID 83687 Phone: 208-467-7654 Fax: 208-318-1391 |
Julie Moore, RN Registered Nurse Medicare: Medicare Enrolled Practice Location: 207 1st St S, Nampa, ID 83651 Phone: 208-466-7869 Fax: 208-466-0009 |
Dorothy Henry, RN Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 144 N. Orchard Heights Way, Nampa, ID 83651 Phone: 208-440-6771 Fax: 888-647-0695 |
Allison Beaman, APRN, FNP-C Registered Nurse - Hospice Medicare: Accepting Medicare Assignments Practice Location: 3904 E Flamingo Ave Ste 100, Nampa, ID 83687 Phone: 208-465-7121 |
News Archive
Diffusion opens enrollment for TSC clinical trial for newly diagnosed primary brain cancer
Diffusion Pharmaceuticals LLC announced today that it has opened for enrollment a clinical trial testing the company's lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.
Researchers figure out 3D shape of promising TB drug target
Researchers at Johns Hopkins have figured out the three-dimensional shape of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis. The bonds make the bacteria resistant to currently available drug therapies, contributing to the alarming rise of these super-bacteria throughout the world.
Bovie settles patent infringement ligation with Salient Surgical and Medtronic
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced a settlement to the June 10, 2010, action brought by Salient Surgical Technologies, Inc. and Medtronic, Inc. against the Company.
New comprehensive study lists top personal health expenses in the U.S.
Just 20 conditions make up more than half of all spending on health care in the United States, according to a new comprehensive financial analysis that examines spending by diseases and injuries.
Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009
Alexion Pharmaceuticals, Inc. today announced financial results for the quarter ended September 30, 2009.
› Verified 8 days ago
- 1
- 2(current)